MeiraGTx (MGTX) Revenue & Revenue Breakdown
MeiraGTx Revenue Highlights
Latest Revenue (Y)
$33.28M
MeiraGTx Revenue by Period
MeiraGTx Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $33.28M | 137.42% |
| 2023-12-31 | $14.02M | -11.95% |
| 2022-12-31 | $15.92M | -57.77% |
| 2021-12-31 | $37.70M | 142.25% |
| 2020-12-31 | $15.56M | 17.09% |
| 2019-12-31 | $13.29M | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | - |
MeiraGTx generated $33.28M in revenue during NA 2024, up 137.42% compared to the previous quarter, and up 250.37% compared to the same period a year ago.
MeiraGTx Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $21.39M | 96.06% |
| 2024-09-30 | $10.91M | 3768.79% |
| 2024-06-30 | $282.00K | -59.54% |
| 2024-03-31 | $697.00K | -65.83% |
| 2023-12-31 | $2.04M | -60.02% |
| 2023-09-30 | $5.10M | 44.15% |
| 2023-06-30 | $3.54M | 6.18% |
| 2023-03-31 | $3.33M | -163.05% |
| 2022-12-31 | $-5.29M | -209.80% |
| 2022-09-30 | $4.82M | -55.24% |
| 2022-06-30 | $10.76M | 91.00% |
| 2022-03-31 | $5.63M | -73.23% |
| 2021-12-31 | $21.04M | 202.91% |
| 2021-09-30 | $6.95M | 35.79% |
| 2021-06-30 | $5.12M | 11.34% |
| 2021-03-31 | $4.59M | 21.31% |
| 2020-12-31 | $3.79M | -25.61% |
| 2020-09-30 | $5.09M | 105.84% |
| 2020-06-30 | $2.47M | -41.24% |
| 2020-03-31 | $4.21M | -39.37% |
| 2019-12-31 | $6.94M | 93.79% |
| 2019-09-30 | $3.58M | 80.79% |
| 2019-06-30 | $1.98M | 152.46% |
| 2019-03-31 | $784.96K | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | - |
MeiraGTx generated - in revenue during Q1 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
MeiraGTx Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| RYTM | Rhythm Pharmaceuticals | $130.13M | $41.83M |
| ANAB | AnaptysBio | $91.28M | $43.11M |
| ETON | Eton Pharmaceuticals | $39.01M | $11.65M |
| MGTX | MeiraGTx | $33.28M | - |
| QURE | uniQure | $27.12M | $5.22M |
| CNTB | Connect Biopharma | $26.03M | - |
| CCCC | C4 Therapeutics | $20.76M | $5.18M |
| GBIO | Generation Bio | $19.89M | $4.19M |
| KRON | Kronos Bio | $9.85M | $2.27M |
| NUVB | Nuvation Bio | $7.87M | $5.71M |
| IDYA | IDEAYA Biosciences | $7.00M | $7.00M |
| KROS | Keros Therapeutics | $3.55M | $3.04M |
| SLDB | Solid Biosciences | - | - |
| RCKT | Rocket Pharmaceuticals | - | - |
| EWTX | Edgewise Therapeutics | - | - |
| ABOS | Acumen Pharmaceuticals | - | - |
| ERAS | Erasca | - | - |
| ELDN | Eledon Pharmaceuticals | - | $192.00K |